Trastuzumab MMAE Antibody
Trastuzumab MMAE is an antibody-drug conjugate (ADC) designed for HER2-positive breast cancer research. It facilitates targeted delivery of the cytotoxic agent MMAE to HER2-overexpressing cells, enabling investigation of its mechanisms and efficacy in both in vitro and in vivo experimental models.
Product Specifications
Target
Antibody-Drug Conjugates (ADCs), Microtubule Associated, EGFR
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Signal Transduction
Molecular Weight
150.63 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC041879-500 1x 500 µL
Bcl-2 (Apoptosis & Follicular Lymphoma Marker) (rBCL2/796), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
